MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Olfactory dysfunction"

  • 2018 International Congress

    A53T mutant human α-synuclein BAC transgenic mice as a model for Parkinson’s disease

    T. Taguchi, I. Masashi, M. Uemura, Y. Hatanaka, N. Uemura, H. Yamakado, R. Takahashi (Kyoto, Japan)

    Objective: The aim of this study is to create mouse models reproducing the course of PD pathology and symptoms. Background: Parkinson's disease (PD) is a…
  • 2018 International Congress

    Olfactory impairment correlates strongly with limbic blood flow in patients with Parkinson’s disease

    K. Ohta, T. Nakajima (Niigata, Japan)

    Objective: To examine the cerebral blood flow pattern of patients of Parkinson's disease with olfactory disorders, and to investigate the correlation between olfactory impairment and…
  • 2018 International Congress

    Olfactory dysfunction, sleep disturbances, neuronal loss, and regional brain atrophy in an inducible mouse model of Alpha-Synucleinopathy

    E. Brison, S. Zehntner, A. Zijdenbos, K. Luk, B. Bedell (Montreal, QC, Canada)

    Objective: The objective of this work is to develop a unique mouse model of spreading α-synucleinopathy to accelerate the development of novel disease-modifying treatments for…
  • 2018 International Congress

    Association of Olfaction dysfunction with Brain Microstructure in Prodromal Parkinson disease

    H. Sanjari Moghaddam, M.H. Aarabi, Z. Valitabar (Tehran, Islamic Republic of Iran)

    Objective: Investigating the association between olfactory dysfunction and connectometry patterns in UPSIT-matched prodromal and PD patients. Background: Parkinson’s disease (PD) is a heterogeneous neurodegenerative disease…
  • 2018 International Congress

    Striatal dopamine uptake and olfactory dysfunction in patients with early Parkinson’s disease

    YS. Oh, DW. Ryu, JS. Kim, CH. Lyoo (Seoul, Republic of Korea)

    Objective: To identify dopamine transporter status of corpus striatum and thalamus using magnetic resonance imaging-guided spatial normalization method in patients with PD according to olfactory…
  • 2018 International Congress

    Clinical and imaging progression in the PARS cohort: Results from 6 years of observation

    D. Jennings, A. Siderowf, S. Eberly, D. Oakes, M. Stern, K. Marek (New Haven, CT, USA)

    Objective: The goal of the Parkinson Associated Risk Syndrome (PARS) study is to explore the clinical and biomarker trajectory of individuals in the pre-motor phase…
  • 2018 International Congress

    Diffusion tensor imaging of olfactory tract in Parkinson’s disease

    P. Nigro, N. Tambasco, A. Chiappiniello, S. Simoni, E. Brahimi, M. Romoli, F. Paolini Paoletti, M. Filidei, P. Calabresi (Perugia, Italy)

    Objective: We investigated the possible relationships among olfactory impairment and alterations in diffusion tensor imaging (DTI) of olfactory tracts, comparing a cohort of patients with…
  • 2018 International Congress

    Gender differences in olfactory dysfunctions in Sardinian patients affected by Parkinson’s disease

    P. Solla, C. Masala, A. Cannas, G. Defazio (Cagliari, Italy)

    Objective: To investigate the presence of specific gender-related patterns in olfactory dysfunctions among Sardinian patients affected by Parkinson's disease (PD), compared with age and sex-matched…
  • 2018 International Congress

    Asymmetric olfactory deficit in H&Y stage-1 early onset Parkinson’s disease

    J. Wang, R. Stanford, L. Spreen, T. Subramanian, Q. Yang (Hershey, PA, USA)

    Objective: To determine if the olfactory deficit in the early-stage Parkinson’s disease (PD) is asymmetric between the two hemispheres ipsilateral and contralateral to the onset…
  • 2018 International Congress

    Selection of odorants for diagnosis of Parkinson’s disease

    O. Izhboldina, N. Zhukova, V. Alifirova, A. Latypova, I. Zhukova, .Uu. Mironova, M. Nikitina, E. Kolupaeva (Tomsk, Russia)

    Objective: The goal of this study was to identify the subset of Sniffin Sticks Test odorants that could be used to differentiate patients with Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 15
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley